Transcriptional Effects of Chronic Akt Activation in the Heart
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Akt activation reduces cardiomyocyte death and induces cardiac hypertrophy. To help identify effector mechanisms, gene expression profiles in hearts from transgenic mice with cardiac-specific expression of activated Akt (myr-Akt) were compared with littermate controls. 40 genes were identified as differentially expressed. Quantitative reverse transcription-PCR confirmed qualitative results of transcript profiling for 9 of 10 genes examined, however, there were notable quantitative discrepancies between the quantitative reverse transcription-PCR and microarray data sets. Interestingly Akt induced significant up-regulation of insulin-like growth factor-binding protein-5 (IGFBP-5), which could contribute to its anti-apoptotic effects in the heart. In addition, Akt-mediated down-regulation of peroxisome proliferator-activated receptor (PPAR) gamma coactivator-1 (PGC-1) and PPAR-alpha may shift myocytes toward glycolytic metabolism shown to preserve cardiomyocyte function and survival during transient ischemia. IGFBP-5 transcripts also increased after adenoviral gene transfer of myr-Akt to cultured cardiomyocytes, suggesting that this represents a direct effect of Akt activation. In contrast, substantial induction of growth differentiation factor-8 (GDF-8), a highly conserved inhibitor of skeletal muscle growth, was observed in transgenic hearts but not after acute Akt activation in vitro, suggesting that GDF-8 induction may represent a secondary effect perhaps related to the cardiac hypertrophy seen in these mice. Thus, microarray analysis reveals previously unappreciated Akt regulation of genes that could contribute to the effects of Akt on cardiomyocyte survival, metabolism, and growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AKT phosphorylates and inhibits PGC-1α in response to insulin in liver [68] and activation of AKT causes a reduction in PGC-1α levels in heart [69].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [69]
In the citing paper
“AKT is a negative regulator of PGC-1α (Figure 3B).”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [69]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Bustin, S. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250169 · Cited by 3,872
Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436
Double muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase
Nidai Ozes, O., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., & Donner, D. B. (1999) · Nature · doi:10.1038/43466 · Cited by 1,832
PI3K: Downstream AKTion Blocks Apoptosis
Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81883-8 · Cited by 1,668
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,517
Cited by
Loffredo, F. S., Steinhauser, M. L., Jay, S. M., Gannon, J., Pancoast, J. R., Yalamanchi, P., Sinha, M., Dall’Osso, C., Khong, D., Shadrach, J. L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.015 · Cited by 948
Transcriptional control of mitochondrial biogenesis: the central role of PGC-1
Ventura-Clapier, R., Garnier, A., & Veksler, V. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn098 · Cited by 932
“Elevated Akt activity has been demonstrated in the failing heart,(88) and overexpression of Akt has been shown to induce a 3-fold downregulation of PGC-1a gene expression.(92) The downregulation of mitochondrial transcription factors induced by postinfarction remodelling can be significantly attenuated by Naþ/Hþ excha…”
BackgroundMicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice
Callis, T. E., Pandya, K., Seok, H. Y., Tang, R.-H., Tatsuguchi, M., Huang, Z.-P., Chen, J.-F., Deng, Z., Gunn, B., Shumate, J., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36154 · Cited by 861
Ceramides in insulin resistance and lipotoxicity
SUMMERS, S. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.002 · Cited by 848
Role of Akt/protein kinase B in metabolism
Whiteman, E. L., Cho, H., & Birnbaum, M. J. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(02)00662-8 · Cited by 676
Holland, W. L., & Summers, S. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0025 · Cited by 595
Cardiac Myocyte Cell Cycle Control in Development, Disease, and Regeneration
Ahuja, P., Sdek, P., & MacLellan, W. R. (2007) · Physiological Reviews · doi:10.1152/physrev.00032.2006 · Cited by 568
Gene Expression in Fibroblasts and Fibrosis: Involvement in Cardiac Hypertrophy
Manabe, I., Shindo, T., & Nagai, R. (2002) · Circulation Research · doi:10.1161/01.res.0000046452.67724.b8 · Cited by 512
Energy metabolism in heart failure
Ventura‐Clapier, R., Garnier, A., & Veksler, V. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2003.055095 · Cited by 499
MicroRNA Regulatory Networks in Cardiovascular Development
Liu, N., & Olson, E. N. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.03.010 · Cited by 491
The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease
OUDIT, G. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.015 · Cited by 469
Porstmann, T., Griffiths, B., Chung, Y.-L., Delpuech, O., Griffiths, J. R., Downward, J., & Schulze, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208802 · Cited by 455
Garnier, A., Fortin, D., Deloménie, C., Momken, I., Veksler, V., & Ventura‐Clapier, R. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.045104 · Cited by 427
Return to the fetal gene program protects the stressed heart: a strong hypothesis
Rajabi, M., Kassiotis, C., Razeghi, P., & Taegtmeyer, H. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9034-1 · Cited by 426
Return to the fetal gene program: A suggested metabolic link to gene expression in the heart
Taegtmeyer, H., Sen, S., & Vela, D. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05100.x · Cited by 411
McMullen, J. R., Shioi, T., Huang, W.-Y., Zhang, L., Tarnavski, O., Bisping, E., Schinke, M., Kong, S., Sherwood, M. C., Brown, J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310405200 · Cited by 404
Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway
Shiojima, I., & Walsh, K. (2006) · Genes & Development · doi:10.1101/gad.1492806 · Cited by 356
Pasha, Z., Wang, Y., Sheikh, R., Zhang, D., Zhao, T., & Ashraf, M. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm025 · Cited by 297
Mechanisms of the free fatty acid-induced increase in hepatic glucose production
Lam, T. K. T., Carpentier, A., Lewis, G. F., van de Werve, G., Fantus, I. G., & Giacca, A. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00033.2003 · Cited by 284
MATSUI, T., & ROSENZWEIG, A. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.11.005 · Cited by 261
Self-citationRegulation of PGC-1 Promoter Activity by Protein Kinase B and the Forkhead Transcription Factor FKHR
Daitoku, H., Yamagata, K., Matsuzaki, H., Hatta, M., & Fukamizu, A. (2003) · Diabetes · doi:10.2337/diabetes.52.3.642 · Cited by 262
Clinical, Agricultural, and Evolutionary Biology of Myostatin: A Comparative Review
Rodgers, B. D., & Garikipati, D. K. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0003 · Cited by 237
Cardiac regulation by phosphoinositide 3-kinases and PTEN
Oudit, G. Y., & Penninger, J. M. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvp014 · Cited by 247
Involvement of PPAR nuclear receptors in tissue injury and wound repair
Michalik, L. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27958 · Cited by 239
Myocardial AKT: The Omnipresent Nexus
Sussman, M. A., Völkers, M., Fischer, K., Bailey, B., Cottage, C. T., Din, S., Gude, N., Avitabile, D., Alvarez, R., Sundararaman, B., et al. (2011) · Physiological Reviews · doi:10.1152/physrev.00024.2010 · Cited by 229
Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure
Heineke, J., Auger-Messier, M., Xu, J., Sargent, M., York, A., Welle, S., & Molkentin, J. D. (2010) · Circulation · doi:10.1161/circulationaha.109.882068 · Cited by 238
Nagoshi, T., Matsui, T., Aoyama, T., Leri, A., Anversa, P., Li, L., Ogawa, W., del Monte, F., Gwathmey, J. K., Grazette, L., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23073 · Cited by 230
Self-citationMyostatin Inhibits IGF-I-Induced Myotube Hypertrophy through Akt
Morissette, M. R., Cook, S. A., Buranasombati, C., Rosenberg, M. A., & Rosenzweig, A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00043.2009 · Cited by 231
Self-citationNuclear Targeting of Akt Enhances Kinase Activity and Survival of Cardiomyocytes
Shiraishi, I., Melendez, J., Ahn, Y., Skavdahl, M., Murphy, E., Welch, S., Schaefer, E., Walsh, K., Rosenzweig, A., Torella, D., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000124394.01180.be · Cited by 212
Self-citationRegulation of Mitochondrial Biogenesis and Its Intersection with Inflammatory Responses
Cherry, A. D., & Piantadosi, C. A. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.6200 · Cited by 187
Akt in Ischemia and Reperfusion
Mullonkal, C. J., & Toledo-Pereyra, L. H. (2007) · Journal of Investigative Surgery · doi:10.1080/08941930701366471 · Cited by 175
Wang, Y., Feng, W., Xue, W., Tan, Y., Hein, D. W., Li, X.-K., & Cai, L. (2009) · Diabetes · doi:10.2337/db08-1697 · Cited by 167
PGC-1α in aging and anti-aging interventions
Anderson, R., & Prolla, T. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.04.005 · Cited by 162
“AKT phosphorylates and inhibits PGC-1α in response to insulin in liver [68] and activation of AKT causes a reduction in PGC-1α levels in heart [69].”
Myostatin Regulates Cardiomyocyte Growth Through Modulation of Akt Signaling
Morissette, M. R., Cook, S. A., Foo, S., McKoy, G., Ashida, N., Novikov, M., Scherrer-Crosbie, M., Li, L., Matsui, T., Brooks, G., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000231290.45676.d4 · Cited by 153
Self-citationGrabacka, M., Plonka, P. M., Urbańska, K., & Reiss, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2556 · Cited by 154
Abnormalities of glucose and lipid metabolism in myocardial ischemia-reperfusion injury
Tian, H., Zhao, X., Zhang, Y., & Xia, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114827 · Cited by 157
Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting
Breitbart, A., Auger-Messier, M., Molkentin, J. D., & Heineke, J. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00200.2011 · Cited by 131
Lenk, K., Schur, R., Linke, A., Erbs, S., Matsumoto, Y., Adams, V., & Schuler, G. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp020 · Cited by 136
Myostatin activation in patients with advanced heart failure and after mechanical unloading
George, I., Bish, L. T., Kamalakkannan, G., Petrilli, C. M., Oz, M. C., Naka, Y., Lee Sweeney, H., & Maybaum, S. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq039 · Cited by 136
Bogoyevitch, M. A. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.03.017 · Cited by 146
Oudit, G. Y., Kassiri, Z., Zhou, J., Liu, Q. C., Liu, P. P., Backx, P. H., Dawood, F., Crackower, M. A., Scholey, J. W., & Penninger, J. M. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn041 · Cited by 123
WANG, Y., AHMAD, N., Wani, M. A., & ASHRAF, M. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.09.004 · Cited by 123
Mechanism of Enhanced Cardiac Function in Mice with Hypertrophy Induced by Overexpressed Akt
Kim, Y.-K., Kim, S.-J., Yatani, A., Huang, Y., Castelli, G., Vatner, D. E., Liu, J., Zhang, Q., Diaz, G., Zieba, R., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305909200 · Cited by 121
Mitochondrial Biogenesis in Health and Disease. Molecular and Therapeutic Approaches
Sanchis-Gomar, F., Garcia-Gimenez, J., Gomez-Cabrera, M., & Pallardo, F. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140306095106 · Cited by 118
Esfandiarei, M., Luo, H., Yanagawa, B., Suarez, A., Dabiri, D., Zhang, J., & McManus, B. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.8.4289-4298.2004 · Cited by 120
Ras, Akt, and Mechanotransduction in the Cardiac Myocyte
Sugden, P. H. (2003) · Circulation Research · doi:10.1161/01.res.0000106132.04301.f5 · Cited by 132
PGC-1 Proteins and Heart Failure
Riehle, C., & Abel, E. D. (2012) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.07.003 · Cited by 119
Switching Metabolic Genes to Build a Better Heart
Taegtmeyer, H. (2002) · Circulation · doi:10.1161/01.cir.0000036760.42319.3f · Cited by 110
Akt Promotes Increased Cardiomyocyte Cycling and Expansion of the Cardiac Progenitor Cell Population
Gude, N. A., Muraski, J. A., Rubio, M., Kajstura, J., Schaefer, E., Anversa, P., & Sussman, M. A. (2006) · Circulation Research · doi:10.1161/01.res.0000236754.21499.1c · Cited by 107
Corton, J. C., & Brown-Borg, H. M. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.12.1494 · Cited by 106
Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue
Miyamoto, S., Murphy, A. N., & Brown, J. H. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9205-y · Cited by 104
Shyu, K., KO, W., Yang, W., Wang, B., & Kuan, P. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.06.028 · Cited by 114
Myostatin Regulates Energy Homeostasis in the Heart and Prevents Heart Failure
Biesemann, N., Mendler, L., Wietelmann, A., Hermann, S., Schäfers, M. A., Krüger, M., Boettger, T., Borchardt, T., & Braun, T. W. (2014) · Circulation Research · doi:10.1161/circresaha.115.304185 · Cited by 105
Myostatin expression in ventricular myocardium in a rat model of volume‐overload heart failure
Shyu, K. G., Lu, M. J., Wang, B. W., Sun, H. Y., & Chang, H. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01718.x · Cited by 100
Cell-based therapy for prevention and reversal of myocardial remodeling
Karantalis, V., Balkan, W., Schulman, I. H., Hatzistergos, K. E., & Hare, J. M. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00221.2012 · Cited by 98
Manna, P., & Jain, S. K. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373949 · Cited by 94
NEF, H. M., Möllmann, H., Troidl, C., Sawa Kostin, D., Boettger, T., Voss, S., Hilpert, P., Krause, N., Weber, M. W., Rolf, A., et al. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.10.015 · Cited by 88
H11 Kinase Is a Novel Mediator of Myocardial Hypertrophy In Vivo
Depré, C., Hase, M., Gaussin, V., Zając, A., Wang, L., Hittinger, L., Ghaleh, B., Yu, X., Kudej, R. K., Wagner, T. E., et al. (2002) · Circulation Research · doi:10.1161/01.res.0000044380.54893.4b · Cited by 88
Myostatin: a skeletal muscle chalone
Lee, S.-J. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012422-112116 · Cited by 84
Nediani, C., Raimondi, L., Borchi, E., & Cerbai, E. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3198 · Cited by 89
Guaiquil, V. H., Golde, D. W., Beckles, D. L., Mascareno, E. J., & Siddiqui, M. A. Q. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.041 · Cited by 91
Xu, E., Schwab, M. G., & Marette, A. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9282-4 · Cited by 86
IGF-1 Expression in Infarcted Myocardium and MGF E Peptide Actions in Rat Cardiomyocytes in Vitro
Stavropoulou, A., Halapas, A., Sourla, A., Philippou, Α., Papageorgiou, E. G., Papalois, A. E., & Koutsilieris, M. (2009) · Molecular Medicine · doi:10.2119/molmed.2009.00012 · Cited by 75
Myostatin represses physiological hypertrophy of the heart and excitation–contraction coupling
Rodgers, B. D., Interlichia, J. P., Garikipati, D. K., Mamidi, R., Chandra, M., Nelson, O. L., Murry, C. E., & Santana, L. F. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.172544 · Cited by 73
Work-induced changes in skeletal muscle IGF-1 and myostatin gene expression in uremia
Sun, D., Chen, Y., & Rabkin, R. (2006) · Kidney International · doi:10.1038/sj.ki.5001532 · Cited by 84
Physiological activation of Akt by PHLPP1 deletion protects against pathological hypertrophy
Moc, C., Taylor, A. E., Chesini, G. P., Zambrano, C. M., Barlow, M. S., Zhang, X., Gustafsson, Å. B., & Purcell, N. H. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu243 · Cited by 76
Matsakas, A., Bozzo, C., Cacciani, N., Caliaro, F., Reggiani, C., Mascarello, F., & Patruno, M. (2006) · Experimental Physiology · doi:10.1113/expphysiol.2006.033571 · Cited by 71
Adam, R. M., Roth, J. A., Cheng, H.-L., Rice, D. C., KHOURY, J., Bauer, S. B., Peters, C. A., & Freeman, M. R. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000063980.99368.35 · Cited by 73
Jackson, M. F., Luong, D., Vang, D. D., Garikipati, D. K., Stanton, J. B., Nelson, O. L., & Rodgers, B. D. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0455 · Cited by 64
Microarray analysis: a novel research tool for cardiovascular scientists and physicians
Napoli, C., Lerman, L. O., Sica, V, Lerman, A., Tajana, G., & de Nigris, F. (2003) · Heart · doi:10.1136/heart.89.6.597 · Cited by 69
Acute hyperglycemia abolishes cardioprotection by remote ischemic perconditioning
Baranyai, T., Nagy, C. T., Koncsos, G., Onódi, Z., Károlyi-Szabó, M., Makkos, A., Varga, Z. V., Ferdinandy, P., & Giricz, Z. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0313-1 · Cited by 66
Puskás, L. G., Nagy, Z. B., Giricz, Z., Ónody, A., Csonka, C., Kitajka, K., Hackler, L., Zvara, Á., & Ferdinandy, P. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00189-9 · Cited by 66
Differential myocardial gene expression in the development and rescue of murine heart failure
Blaxall, B. C., Spang, R., Rockman, H. A., & Koch, W. J. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00087.2003 · Cited by 65
Gleason, C. E., Ning, Y., Cominski, T. P., Gupta, R. K., Kaestner, K. H., Pintar, J. E., & Birnbaum, M. J. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0167 · Cited by 63
Regeneration of infarcted myocardium with resveratrol‐modified cardiac stem cells
Gorbunov, N. V., Petrovski, G., Gurusamy, N., Ray, D., Kim, D. H., & Das, D. K. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01281.x · Cited by 63
Inactivation of glycogen synthase kinase-3β (GSK-3β) enhances skeletal muscle oxidative metabolism
Theeuwes, W. F., Gosker, H. R., LANGEN, R. C. J., Verhees, K. J. P., Pansters, N., Schols, A. M. W. J., & Remels, A. H. V. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.09.018 · Cited by 67
A20 Is Dynamically Regulated in the Heart and Inhibits the Hypertrophic Response
Cook, S. A., Novikov, M. S., Ahn, Y., Matsui, T., & Rosenzweig, A. (2003) · Circulation · doi:10.1161/01.cir.0000086978.95976.41 · Cited by 62
Self-citationDNA Microarrays: Implications for Cardiovascular Medicine
Cook, S. A., & Rosenzweig, A. (2002) · Circulation Research · doi:10.1161/01.res.0000036019.55901.62 · Cited by 60
Self-citationDeletion of Akt1 causes heart defects and abnormal cardiomyocyte proliferation
Chang, Z., Zhang, Q., Feng, Q., Xu, J., Teng, T., Luan, Q., Shan, C., Hu, Y., Hemmings, B. A., Gao, X., et al. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.08.033 · Cited by 65
Artaza, J. N., Reisz-Porszasz, S., Dow, J. S., Kloner, R. A., Tsao, J., Bhasin, S., & Gonzalez-Cadavid, N. F. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0072 · Cited by 56
Kovács, K. A., Lengyel, F., Környei, J., Vértes, Z., Szabó, I., Sümegi, B., & Vértes, M. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2003.09.007 · Cited by 58
Uremic Cardiomyopathy and Insulin Resistance: A Critical Role for Akt?
Semple, D. J., Smith, K., Bhandari, S., & Seymour, A. L. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009090900 · Cited by 58
Effects of chronic Akt activation on glucose uptake in the heart
Matsui, T., Nagoshi, T., Hong, E., Luptak, I., Hartil, K., Li, L., Gorovits, N., Charron, M. J., Kim, J. K., Tian, R., et al. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00564.2004 · Cited by 56
Self-citationQi, H., Ren, J., Ba, L., Song, C., Zhang, Q., Cao, Y., Shi, P., Fu, B., Liu, Y., & Sun, H. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.12.003 · Cited by 55
Insulin signaling in heart muscle: Lessons from genetically engineered mouse models
Abel, E. D. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0034-4 · Cited by 54
Atherosclerotic Plaque Smooth Muscle Cells Have a Distinct Phenotype
Mulvihill, E. R., Jaeger, J. C., Sengupta, R., Ruzzo, W. L., Reimer, C., Lukito, S., & Schwartz, S. M. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000132401.12275.0c · Cited by 62
Epo and Non-hematopoietic Cells: What Do We Know?
Ogunshola, O. O., & Bogdanova, A. Y. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-308-4_2 · Cited by 60
Zvara, Á., Bencsik, P., Fodor, G., Csont, T., Hackler, L., Dux, M., Fürst, S., Jancsó, G., Puskás, L. G., & Ferdinándy, P. (2005) · The FASEB Journal · doi:10.1096/fj.05-4060fje · Cited by 53
Hu, X., Xu, X., Huang, Y., Fassett, J., Flagg, T. P., Zhang, Y., Nichols, C. G., Bache, R. J., & Chen, Y. (2008) · Circulation Research · doi:10.1161/circresaha.107.170795 · Cited by 54
Schiekofer, S., Shiojima, I., Sato, K., Galasso, G., Oshima, Y., & Walsh, K. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00234.2005 · Cited by 53
PPARs: Protectors or Opponents of Myocardial Function?
Pol, C. J., Lieu, M., & Drosatos, K. (2015) · PPAR Research · doi:10.1155/2015/835985 · Cited by 55
Peroxisome Proliferator-Activated Receptors and the Cardiovascular System
Chen, Y. E., Fu, M., Zhang, J., Zhu, X., Lin, Y., Akinbami, M. A., & Song, Q. (2003) · Vitamins and hormones · doi:10.1016/s0083-6729(03)01005-7 · Cited by 53
Athlete’s Heart Revisited: Historical, Clinical, and Molecular Perspectives
Hsieh, P. N., Shen, S., Chukwurah, M. I., Churchill, T. W., Stewart, K. M., Chung, E. H., Weiner, R. B., Li, H., & Guseh, J. S. (2025) · Circulation Research · doi:10.1161/circresaha.125.325638 · Cited by 51
Role of Phosphatidylinositol 3,4,5-Trisphosphate in Cell Signaling
Riehle, R. D., Cornea, S., & Degterev, A. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-6331-9_7 · Cited by 58
The histone deacetylase SIRT6 blocks myostatin expression and development of muscle atrophy
Samant, S. A., Kanwal, A., Pillai, V. B., Bao, R., & Gupta, M. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-10838-5 · Cited by 46
Wang, B.-W., Chang, H., Kuan, P., & Shyu, K. (2008) · Journal of Endocrinology · doi:10.1677/joe-07-0596 · Cited by 48
Javadov, S. A., Purdham, D. M., Zeidan, A., & Karmazyn, M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00159.2006 · Cited by 51
PGC-1α Gly482Ser Polymorphism Associates With Hypertension Among Danish Whites
Andersen, G., Thørner, L. W., Jensen, D. P., Glümer, C., Tarnow, L., Drivsholm, T., Poulsen, P., Hansen, S. K., Nielsen, E.-M. D., Ek, J., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000158946.53289.24 · Cited by 50
Mechanisms of Cell Survival in Myocardial Hibernation
Depré, C., & Vatner, S. F. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.04.006 · Cited by 50
Kong, H., Li, Z., Zhao, Y., Zhao, S.-M., Zhu, L., Li, T., Fu, Y., & Li, H. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.52 · Cited by 45
Metadata
- Authors
- Cook, S. A., Matsui, T., Li, L., & Rosenzweig, A.
- Affiliations
- Harvard University (US)
- Corresponding author
- Rosenzweig, Anthony
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 277
- Issue
- 25
- Pages
- 22528-22533
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2014333801
- Cited by
- 199
- References
- 45
- Citations by year
- 2026: 2 · 2025: 2 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 10 · 2015: 10 · 2014: 6 · 2013: 12 · 2012: 8
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6719 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- Funders
- Wellcome Trust
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL61557, HL-59521, R01HL061557, HL04250, R01HL059521, K08HL004250)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- Akt activation, cardiomyocyte survival, cardiac hypertrophy, IGFBP-5, PGC-1, PPARα, glycolytic metabolism, myostatin, cardiomyocyte apoptosis, myocardial ischemia
- MeSH terms
- Adenoviridae, Animals, Cell Division, Enzyme Activation, Gene Expression Regulation, Heart, Mice, Inbred C57BL, Myocardium, Proto-Oncogene Proteins, RNA, Messenger, Temperature, Transcription Factors, Transcription, Genetic, Immunoblotting, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, RNA, Complementary, DNA, Complementary, Receptors, Cytoplasmic and Nuclear, Insulin-Like Growth Factor Binding Protein 5, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Proto-Oncogene Proteins c-akt, Mice, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.